2.3. Cell Viability Assay

IA Iris Aja
MR M. Begoña Ruiz-Larrea
AC Arnaud Courtois
SK Stéphanie Krisa
TR Tristan Richard
JR José-Ignacio Ruiz-Sanz
ask Ask a question
Favorite

Cell lines were seeded into 96-well plates at 5 × 103 (HepG2) and 3 × 103 (Hep3B and HH4) cells/well 24 h before treatment. Increasing concentrations of the monomer trans-resveratrol, the dimers ampelopsin A and trans-ε-viniferin and the tetramers isohopeaphenol, hopeaphenol, R2-viniferin and R-viniferin were then added and cells were incubated for 24, 48, and 72 h. Stilbenes were dissolved in dimethyl sulfoxide (DMSO), Sigma-Aldrich, St Louis, MO, USA) at a final concentration of 0.01%. The same amount of DMSO was added to control cells. After treatment, the cell viability was determined using the crystal violet assay [18]. The absorbance was recorded at 590 nm in a Synergy HT microplate reader (BioTek, Winooski, VT, USA). Cell viability was calculated as the percentage of viable cells treated with stilbene versus untreated control cells using the following equation: Cell viability (%) = [OD (Treatment) − OD (Blank)]/[OD (Control) − OD (Blank)] × 100. The cytotoxic effect of stilbenes was determined by calculating IC50 values using non-linear regression analysis (GraphPad Prism 6, San Diego, CA, USA).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A